Here’s what to know about the order and its potential impact on drug prices in the U.S. Could the Executive Order actually lower drug prices? Experts say it’s unclear how effe

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore pharmaceutical manufacturing.

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United States, the company said on Wednesday. Trump's order, signed on Monday, directs drugmakers to lower prices of brand-name medicines to align with those in other wealthy nations.